Advertisement
Canada markets closed
  • S&P/TSX

    21,873.72
    -138.00 (-0.63%)
     
  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     
  • DOW

    38,460.92
    -42.77 (-0.11%)
     
  • CAD/USD

    0.7302
    +0.0004 (+0.05%)
     
  • CRUDE OIL

    82.61
    -0.20 (-0.24%)
     
  • Bitcoin CAD

    87,605.30
    -3,758.36 (-4.11%)
     
  • CMC Crypto 200

    1,391.26
    -32.84 (-2.31%)
     
  • GOLD FUTURES

    2,330.70
    -7.70 (-0.33%)
     
  • RUSSELL 2000

    1,995.43
    -7.22 (-0.36%)
     
  • 10-Yr Bond

    4.6520
    +0.0540 (+1.17%)
     
  • NASDAQ futures

    17,469.00
    -195.50 (-1.11%)
     
  • VOLATILITY

    15.97
    +0.28 (+1.78%)
     
  • FTSE

    8,040.38
    -4.43 (-0.06%)
     
  • NIKKEI 225

    37,762.47
    -697.61 (-1.81%)
     
  • CAD/EUR

    0.6817
    -0.0002 (-0.03%)
     

Gauging Novartis’s Valuation This November

Novartis saw revenues of ~$12.4 billion and EPS of $1.29 for 3Q17, which represents a 2% YoY rise, compared with its revenues of ~$12.1 billion in 3Q16.